Linezolid Injection in 0.9% Sodium Chloride

2 mg/mL

600 mg/300 mL

Flexible Container

Unit of Sale NDC: 00409-4883-10

Depleted
To set product alerts you must or register

Cap color: N/A

Wholesalers
Cardinal 5855887
Cencora 10280845
McKesson 2830271
Morris & Dickson 290981
Ordering information
Unit of Sale size 1 case of 10 containers
Case size 1 x 10
Cases per tier 1
Cases per pallet 90
Unit of Sale dimensions 15.20 x 7.70 x 6.40
Unit of Sale weight 7.963
Shipper outer dimensions 15.20 x 7.70 x 6.40
Shipper weight 7.963
Allergy information
Non-DEHP
Latex information
Gluten free
Availability specifics
Additional information View

If Latex Information is present above, then natural rubber latex has not been used in the manufacturing of this device or drug container closure system.

If Preservative Free is present above, then this product does not contain ingredients identified as a preservative, as defined by the USP.

Cap color: N/A

Unit of Sale NDC:00409-4883-10

Linezolid Injection in 0.9% Sodium Chloride

Unit of Use NDC:00409-4883-03

Linezolid Injection in 0.9% Sodium Chloride

Related news

Product Updates

Product NDC Change: Fluconazole in Sodium Chloride Injection, USP 400 mg/200 mL (2 mg/mL) Flexible Container

Product Updates

Product NDC Change: Fluconazole in Sodium Chloride Injection, USP 200 mg/100 mL (2 mg/mL) Flexible Container

Product Updates

Product NDC and Pack Size Change: Marcaine® 0.5% (bupivacaine hydrochloride injection, USP) 50 mg/10 mL (5 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC Change: Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC Change: Midazolam Injection, USP CIV 2 mg/2 mL (1 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change for Metoclopramide Injection, USP 10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change for Camptosar® (Irinotecan Hydrochloride Injection, USP) 300 mg/15 mL (20 mg/mL) Single Dose Vial

Product Updates

NDC and Formulation Change for Levofloxacin in 5% Dextrose Injection Flexible Container Presentations

Product Updates

NDC Change for Idamycin PFS® (idarubicin hydrochloride injection), 10 mg/10 mL (1 mg/mL) Single Dose Vial

Product Updates

NDC Change for Idamycin PFS® (idarubicin hydrochloride injection), 20 mg/20 mL

Product Updates

NDC and Packaging Change for Labetalol Hydrochloride Injection, USP 100 mg/20 mL (5 mg/mL) Multiple-dose Vial

Product Updates

NDC and Labeling Change: Rocuronium Bromide NDC Labeling Change

Product Updates

NDC and Labeling Change Linezolid Injection in 0.9% Sodium Chloride 600 mg/300 mL (2 mg/mL) Single-dose Container

Product Updates

NDC and Labeling Change: Ciprofloxacin in 5% Dextrose Injection, USP 200 mg/100 mL (2 mg/mL) Single-Dose Flexible Container

Product Updates

NDC and Labeling Change for Magnesium Sulfate in Water for Injection 40 g/1000 mL (40 mg/mL) Single-Dose Flexible Container

Product Updates

Product NDC Change for Ciprofloxacin in 5% Dextrose Injection, USP 400 mg/200 mL (2 mg/mL) Single Dose Flexible Container

Product Updates

NDC and Packaging Update for Heparin Sodium in Sodium Chloride Injection Flexible Container, Multiple Presentations

Product Updates

NDC and Packaging Change for Heparin Sodium in 0.45% Sodium Chloride Injection, 25,000 USP Units/250 mL (100 USP Units/mL) Flexible Container

Product Updates

NDC and Packaging Update for Magnesium Sulfate in Water for Injection Flexible Container, Multiple Presentations

Product Updates

NDC and Packaging Change for Heparin Sodium in 0.45% Sodium Chloride Injection, 25,000 USP Units/500 mL (50 USP Units/mL) Flexible Container

Product Updates

NDC and Packaging Change for Heparin Sodium in 5% Dextrose Injection 25,000 USP Units/250 mL (100 USP Units/mL) Flexible Container